Research.Patient.info

Non-metastatic resectable pancreatic cancer research hub

1 indexed studies · 0 currently recruiting

authorisedTherapeutic confirmatory (Phase III)
Perioperative versus adjuvant FOLFIRINOX for resectable pancreatic cancer: the PREOPANC-3 study
This study looks at treating pancreatic cancer with strong chemotherapy (FOLFIRINOX) either before or after surgery. Researchers want to see if giving it before surgery helps people live longer. It's for adults with pancreatic cancer that hasn't spread and can be removed by surgery.
Netherlands · Sweden